The Manila Times6h
ExoPTEN Preclinical Study Demonstrates Significant Potential for Enhancing Motor Function, Blood Flow, and Spinal Cord Injury Recovery
Scientific publications and reach in the field have shown already that post-injury angiogenesis and vascular remodeling ...
Becker's Spine Review6h
9 recent spine, orthopedic studies to know
From findings about GLP-1s to spine surgery costs, Becker’s reported on nine key studies in spine and orthopedics since Feb. 13. 1. A study of cervical disc replacements in The Spine Journal found ...
The Manila Times14h
Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/b Study of PALI-2108
Positive preliminary data from all five single ascending dose (SAD) cohorts and first three completed multiple ascending dose (MAD) cohorts support safety and tolerability of PALI-2108 No serious ...
TipRanks on MSN6h
NurExone’s ExoPTEN Shows Promising Preclinical Results for Spinal Cord Injury
ExoPTEN, which is advancing towards first-in-human trials. The study demonstrated that ExoPTEN significantly enhances motor function recovery and improves blood flow at spinal cord injury sites, ...
Nektar Therapeutics (NASDAQ:NKTR) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 ...
Neuroscience News5h
Cannabis Terpenes Offer New Hope for Chronic Pain, Fibromyalgia
New research has identified cannabis-derived terpenes—compounds that give plants their distinctive aroma—as effective ...
Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients, expected in 2Q 2025In parallel, the Company continues to analyze data and explore opportunities ...